EVAg

Recombinant humanized monoclonal antibody against Schmallenberg orthobunyavirus, Isotype IgG1 / Igƙ, fused to Venus fluorophore

anti-African swine fever virus (ASFV), clone 2E10B3

Hybridoma cell culture supernatant containing anti-pan Orthobunyavirus antibodies; targeted antigen: Gc; clone: 6B2B2; immunization antigen: recombinant Gc Protein of LACV

anti-SARS-CoV-2 S protein (RBD, aa319-541) monoclonal antibody, clone 5E2B1

anti-SARS-CoV-2 S protein (S1 Ecto, aa1-1215) monoclonal antibody, clone 4B5C1

anti-SARS-CoV-2 S protein (NTD, aa17-304) monoclonal antibody, clone 6A5A3

Generation of recombinant chimeric monoclonal antibodies: murine monoclonal antibodies (hybridoma cells or total RNA have to be provided by the end-user) will be sequenced, cloned, recombinantly expressed in Expi293 cells, and purified via protein G. Available backbones for heavy and light chain constant regions are: mouse IgG1, Ig kappa; mouse IgG2a, Ig kappa; rabbit IgG, Ig kappa; human IgG1, Ig kappa; porcine IgG, Ig kappa; and bovine IgG, Ig kappa. Other backbones could possibly also generated uppon request.

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H12; clone: 20.1.2.a; immunization antigen: several inactivated AIV H8Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H13 and H16; clone: 14.2.6.c; immunization antigen: several inactivated AIV H13Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NA1; clone: 15.2.7.c; immunization antigen: several inactivated AIV H1Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NA2; clone: 4.3.6; immunization antigen: several inactivated AIV HxN2 isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NA7; clone: 17.1.5; immunization antigen: several inactivated AIV HxN7 isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NA8; clone: 14.2.3.b; immunization antigen: several inactivated AIV H3Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NA9 and NA1; clone: 15.2.4; immunization antigen: several inactivated AIV H2Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NP; clone: 11.1.5; immunization antigen: several inactivated AIV isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: NS1; clone: 21.1.1.A; immunization antigen: several inactivated AIV isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: Matrix Protein 1; clone: 4.2.1.A; immunization antigen: several inactivated AIV HxN2 isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H1(0/1); clone: 12.2.2.A; immunization antigen: several inactivated AIV H1Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; clone: 13.2.7; targeted antigen: H2(0/1); immunization antigen: several inactivated AIV H2Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; clone: 18.2.4; targeted antigen: H3; immunization antigen: several inactivated AIV H3Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H4(0); clone: 5.2.4; immunization antigen: several inactivated AIV HxN6 isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H5(0/1); clone: 10.2.1; immunization antigen: several inactivated AIV H5N1 isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H6(0/1); clone: 11.1.7.c; immunization antigen: several inactivated AIV H6Nx isolates

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H7 and H15; clone: 13G11b; immunization antigen: inactivated A/FPV/Dutch/27 (H7N7)

Hybridoma cell culture supernatant containing anti-Influenza A virus antibodies; targeted antigen: H7; clone: 2/1; immunization antigen: inactivated A/FPV/Dutch/27 (H7N7)